| |
|
|
|
Trillium Therapeutics Inc.  
|
|
0.3151 -0.019 (-0.06%) |
06-25 14:07 |
|
Open: |
0.343 |
Pre close: |
0.334 |
Target:
|
0.59 
|
|
High: |
0.3451 |
Low: |
0.3003 |
Resistance:
|
0.51
0.63
|
|
Volume: |
780,822 |
Market Cap: |
9M |
Support:
|
0.30
0.25
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.35
|
MACD |
MACD(12,26):
|
-0.04 |
|
MA(20): |
0.37 |
Signal(12,26,9): |
-0.05  |
|
MA(100): |
0.68 |
Stochastic Oscillator |
%K(14,3):
|
17.33 |
|
MA(250): |
2.67 |
%D(3): |
28.16 |
|
Average Volume(K) |
3-Month: |
95823
|
52-Week |
High:
|
6.75 |
|
10-Days: |
41360 |
Low: |
0.30 |
|
RSI |
RSI(14):
|
30.22 |
Change(%): |
-95.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.548 |
Return on Equity (ttm) |
-78.6 |
Shares Out. (M) |
14.69 |
|
EPS Est. Current Year |
-4.130 |
Return on Assets (ttm) |
-40.6 |
Shares Float (M) |
19.86 |
|
EPS Est. Next Year |
-2.740 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.26 |
|
EPS Est. Next Quarter |
-0.960 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
40.67 |
|
Forward EPS |
-2.917 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1980 |
|
Book Value (p.s.) |
0.090 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.12 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.45 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
